Greenwich Lifesciences Inc (GLSI)
R&D Expense Growth
-31.66%
Quarterly · Period ending:
GLSI R&D Expense Growth
Latest reported-31.66%period ending
Latest reported-31.66%period ending
GLSI Quarterly R&D Growth (QoQ) (0.00% → -31.66%)
Latest values, visible window
High-resolution chart · PNG
GLSI r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -31.6626% | |
| 47.876% | |
| 0% | |
| 0.3897% | |
| 54.4552% | |
| -63.1164% | |
| 168.6516% | |
| -0.686% | |
| 5.1656% | |
| -5.9352% | |
| 8.1001% | |
| 56.438% | |
| -24.5275% | |
| -25.6375% | |
| 42.6234% | |
| 172.1663% | |
| -61.8713% | |
| -19.5303% | |
| 214.0954% | |
| 18.0693% | |
| 97.3686% | |
| -52.9159% | |
| 278.9636% | |
| 4.7923% | |
| 0.6091% | |
| -42.0541% | |
| -9.079% | |
| -85.3113% | |
| 1,432.8543% | |
| -89.1197% | |
| 0% |